Foley & Lardner LLP represented Vive Organic on the deal. Vive Organic, the brand of immunity-supporting booster shots created by holistic medical professionals, announced its recent acquisition...
Suja Life’s Acquisition of Vive Organic
20Cube Logistics’ Business Combination Agreement with Evo Acquisition Corp.
Foley & Lardner LLP represented 20Cube Logistics on the deal. 20Cube Logistics, a software-enabled international supply chain orchestrator, announced a business combination agreement that will enable 20Cube...
Lumotive’s Funding Round
Foley & Lardner LLP represented Samsung Ventures on the deal. Samsung Ventures acted as the lead investor in a round of strategic funding for Lumotive, the...
Eyenuk’s $26 Million Series A Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments, acted as lead investor in the $26...
Cellarity’s $121 Million Series C Funding
Foley & Lardner LLP represented Hanwha Impact Partners on the deal. Hanwha Impact Partners acted as lead investor in the $121 million Series C funding round for...
Flores’ Recapitalization
Foley & Lardner LLP advised Century Equity Partners on the deal. Century Equity Partners and its portfolio company Flores & Associates LLC (Flores), a leading provider...
Material Newborn Health Innovations’ $26 Million Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments with over $190 billion of assets...
Ginkgo Bioworks’ Collaboration Agreement with Merck
Foley Hoag LLP represented Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
Solvento’s $5 Million Seed Financing
Gunderson Dettmer represented Solvento on the deal while Foley & Lardner LLP represented Ironspring Ventures. Solvento announced its $5 million Seed financing led by Ironspring Ventures. Solvento’s...
CXL Ophthalmics’ $32 Million Series A Round of Fundraising
Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts. CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive...
HN Capital Partners’ Acquisition of Iconic Rosewood Mansion
Foley & Lardner LLP advised HN Capital Partners on the deal. Private real estate investment firm HN Capital Partners announced in the acquisition of the iconic Rosewood...
Immerok’s $17 Million Seed Funding Round
Foley & Lardner LLP and Osborne Clarke represented Cortical Ventures on the deal. Cortical Ventures, an AI-focused venture capital firm, acted as an investor in the...